Journal articles

Scientific and review papers

• Tadijan, A., Humphries, J., Samaržija, I., Stojanović, N., Zha, J., Čuljak, K., Tomić, M., Paradžik, M., Nestić, D., Kang, H., Humphries, M. & Ambriović-Ristov, A. (2021) The Tongue Squamous Carcinoma Cell Line Cal27 Primarily Employs Integrin α6β4-Containing Type II Hemidesmosomes for Adhesion Which Contribute to Anticancer Drug Sensitivity. Frontiers in cell and developmental biology, 9, 786758, 17 doi:10.3389/fcell.2021.786758.

  doiwww.frontiersin.orgdoi.orgfulir.irb.hr

• Nestić, D., Božinović, K., Pehar, I., Wallace, R., Parker, A. & Majhen, D. (2021) The Revolving Door of Adenovirus Cell Entry: Not All Pathways Are Equal. Pharmaceutics, 13 (10), 1585, 18 doi:10.3390/pharmaceutics13101585.

  doiwww.mdpi.comdoi.orgfulir.irb.hr

• Božinović, K., Nestić, D., Gradišar Centa, U., Ambriović-Ristov, A., Dekanić, A., de Bisschop, L., Remškar, M. & Majhen, D. (2020) In-vitro toxicity of molybdenum trioxide nanoparticles on human keratinocytes. Toxicology, 444, 152564, 11 doi:10.1016/j.tox.2020.152564.

  doi

• Hulin-Curtis, S., Davies, J., Nestić, D., Bates, E., Baker, A., Cunliffe, T., Majhen, D., Chester, J. & Parker, A. (2020) Identification of folate receptor α (FRα) binding oligopeptides and their evaluation for targeted virotherapy applications. Cancer gene therapy, 27, 785-798 doi:10.1038/s41417-019-0156-0.

  doidoi.orgwww.nature.com

• Paradžik, M., Humphries, J., Stojanović, N., Nestić, D., Majhen, D., Dekanić, A., Samaržija, I., Sedda, D., Weber, I., Humphries, M. & Ambriović-Ristov, A. (2020) KANK2 links αVβ5 focal adhesions to microtubules and regulates sensitivity to microtubule poisons and cell migration. Frontiers in cell and developmental biology, 8, 125, 17 doi:10.3389/fcell.2020.00125.

  doidoi.orgwww.frontiersin.orgfulir.irb.hr

• Nestić, D., Uil, T., Ma, J., Roy, S., Vellinga, J., Baker, A., Custers, J. & Majhen, D. (2018) αvβ3 Integrin is Required for Efficient Infection of Epithelial Cells with Human Adenovirus Type 26. Journal of virology, 93 (1), e01474, 18 doi:10.1128/JVI.01474-18.

  doi